Evaluation of platelet-rich plasma in treatment of alopecia areata: a placebo-controlled study

Hassan A. Fayed,Moustafa A. Elsaied,Marwa R. Faraj,Fayed, Hassan A.,Elsaied, Moustafa A.,Faraj, Marwa R.
DOI: https://doi.org/10.1097/01.EWX.0000540042.97989.cf
2019-10-03
Journal of the Egyptian Women's Dermatologic Society
Abstract:Background Alopecia areata (AA) has major effects on the quality of life and self-esteem, especially in the young patients. Platelet-rich plasma (PRP) promotes hair growth and survival both in vivo and in vitro because of its high concentration of growth factors that stimulate the formation of hair epithelium and the differentiation of stem cells in the hair follicles. Objective To evaluate the efficacy and safety of PRP in the treatment of AA through an open-labeled, nonrandomized, placebo-controlled study and to explore the role of needling in the effect of PRP. Patients and methods This study included 41 patients complaining of multiple patchy AA. PRP was injected in one side by multiple injections intradermally 20 mm apart every 2 weeks for a total of 10 injections or shorter if hair regrowth occurred. Saline was injected in the other side as a control. Evaluation of hair loss and follow-up results were determined using Severity of Alopecia Tool score. Assessment of qualify of life was carried out using the Arabic version questionnaire of dermatology quality of life scales (DQOLs). Results Hair regrowth occurred in 13 (31.7%) patients in the areas injected with PRP, whereas regrowth of hair in placebo areas occurred in two (4.9%) of patients. There was a statistically significant difference between the treatment side and placebo side (P=0.002). Grade1 (S1) showed the best improvement [12/23 (52.3%)], whereas only one patient [1/7 (14.3%)] with grade 2 (S2) had hair regrowth. In contrast, no response occurred in both grade 3 and grade 4 (S3 and S4). There was statistically significant improvement in the mean value of DQOLS after treatment (P=0.002). Conclusion PRP treatment for AA is effective, safe, and easy to perform, improving the patients’ DQOL with minimal tolerable side effects. PRP treatment for AA is effective in mild cases of AA. The efficacy of PRP is mostly not caused by needling, as the saline injection showed less significant improvement. However, further studies are needed to identify the precise dosing and the frequency of sessions needed with prolonged follow-up.
What problem does this paper attempt to address?